Regulation of MMP-2 gene transcription in dermal wounds

Journal of Investigative Dermatology

Volumn 127, Issue 7, 2007, Pages 1762-1767

  Jansen, Petra Lynen ^a   Rosch, Raphael ^a   Jansen, Marc ^a   Binnebösel, Marcel ^a   Junge, Karsten ^a   Alfonso Jaume, Alexandra ^b   Klinge, Uwe ^a   Lovett, David H ^c   Mertens, Peter R ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; PROTEIN; PROTEIN RE 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; ENDOTHELIUM CELL; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HAIR FOLLICLE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REPORTER GENE; SKIN INJURY; SWEAT GLAND; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; WOUND;

ANIMALS; ENDOTHELIAL CELLS; ENHANCER ELEMENTS (GENETICS); FIBROSIS; MACROPHAGES; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; SKIN; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; WOUND HEALING;

EID: 34250615875     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700765     Document Type: Article

References (26)

1. Agren MS (1994) Gelatinase activity during wound healing. Br J Dermatol 131:634-40
2. Corcoran ML, Hewitt RE, Kleiner DE Jr, Stetler-Stevenson WG (1996) MMP-2: expression, activation and inhibition. Enzyme Protein 49:7-19
3. Eerola LM, Alho HS, Maasilta PK, Inkinen KA, Harjula AL, Litmanen SH et al. (2005) Matrix metalloproteinase induction in post-transplant obliterative bronchiolitis. J Heart Lung Transplant 24:426-32
4. Frisch SM, Morisaki JH (1990) Positive and negative transcriptional elements of the human type IV collagenase gene. Mol Cell Biol 10:6524-32
5. Grose R, Werner S (2004) Wound-healing studies in transgenic and knockout mice. Mol Biotechnol 28:147-66
6. Harendza S, Lovett DH, Stahl RAK (2000) The hematopoietic transcription factor PU.1 represses gelatinase A transcription in glomerular mesangial cells. J Biol Chem 275:19552-9
7. Harendza S, Pollock AS, Mertens PR, Lovett DH (1995) Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J Biol Chem 270:18786-96
8. Ishikawa T, Nishigaki F, Miyata S, Hirayama Y, Minoura K, Imanishi J et al. (2005) Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031. Br J Pharmacol 144:133-43
9. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58:1048-51
10. Jackson CJ, Xue M, Thompson P, Davey RA, Whitmont K, Smith S et al. (2005) Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing. Wound Repair Regen 13:284-94
11. Kato T, Kure T, Chang JH, Gabison EE, Itoh T, Itohara S et al. (2001a) Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett 508:187-90
12. Kato T, Kure T, Chang JH, Gabison EE, Itoh T, Itohara S et al. (2001b) Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett 508:187-90
13. Lee JG, Dahi S, Mahimkar R, Tulloch NL, Alfonso-Jaume MA, Lovett DH et al. (2005) Intronic regulation of matrix metalloproteinase-2 revealed by in vivo transcriptional analysis in ischemia. Proc Natl Acad Sci USA 102:16345-50
14. Mandal M, Mandal A, Das S, Chakraborti T, Chakraborti S (2003) Clinical implications of matrix metalloproteinases. Mol Cell Biochem 252:305-29
15. Marti HP, Lee L, Kashgarian M, Lovett DH (1994) Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am J Pathol 144:82-94
16. Mertens PR, Alfonso-Jaume MA, Steinmann K, Lovett DH (1998) A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J Biol Chem 273:32957-65
17. Mertens PR, Alfonso-Jaume MA, Steinmann K, Lovett DH (1999) YB-1 regulation of the human and rat gelatinase A genes via similar enhancer elements. J Am Soc Nephrol 10:2480-7
18. Mertens PR, Harendza S, Pollock AS, Lovett DH (1997) Glomerular Mesangial Cell-specific Transactivation of Matrix Metalloproteinase 2á Transcription Is Mediated by YB-1. J Biol Chem 272:22905-12
19. Mertens PR, Steinmann K, Alfonso-Jaume MA, En-Nia A, Sun Y, Lovett DH (2002) Combinatorial interactions of p53, AP2 and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells. J Biol Chem 277:24875-82
20. Miyake T, Aoki M, Nakashima H, Kawasaki T, Oishi M, Kataoka K et al. (2006) Prevention of abdominal aortic aneurysms by simultaneous inhibition of NF[kappa]B and ets using chimeric decoy oligonucleotides in a rabbit model. Gene Ther 13:695-704
21. Overall CM, Lopez-Otin C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657-72
22. Samolov B, Steen B, Seregard S, van dP I, Montan P, Kvanta A (2005) Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice. Exp Eye Res 80:159-66
23. Turck J, Pollock AS, Lee LK, Marti HP, Lovett DH (1996) Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J Biol Chem 271:15074-83
24. Vaisanen A, Tuominen H, Kallioinen M, Turpeenniemi-Hujanen T (1996) Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol 180:283-9
25. Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835-70
26. Wu M, Li YG (2006) The expression of CD40-CD40L and activities of matrix metalloproteinases in atherosclerotic rats. Mol Cell Biochem 282:141-6